Merit Medical outlined the ongoing succession planning process for its CEO. Pursuant to an amended and restated employment agreement, effective June 8, Merit founder, CEO, and president, Fred Lampropoulos, will continue to serve as Merit’s CEO and president through December 31, 2025. To carry out its responsibility for CEO succession, the Merit board of directors appointed a special steering committee of independent directors led by Ann Millner, lead independent director. The committee is developing and providing oversight of a succession plan in preparation for Lampropoulos’ retirement. The plan is also intended to prepare the company for a CEO transition at the appropriate time. Korn Ferry.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MMSI:
- Merit Medical Announces Process for Chief Executive Officer Succession Planning
- Merit Medical management to meet with Oppenheimer
- Merit Medical Announces Pricing of Upsized Private Offering of $650.0 Million of 3.00% Convertible Senior Notes Due 2029
- Merit Medical Announces Proposed Private Placement of $550 Million of Convertible Senior Notes
- Merit Medical announces private placement of $550M convertible senior notes
